O'Reilly, M.S., Holmgren, L., Chen, C. & Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med.2, 689–692 (1996). ArticleCASPubMed Google Scholar
O'Reilly, M.S. et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell88, 277–285 (1997). ArticleCASPubMed Google Scholar
Augustin, H.G. Antiangiogenic tumor therapy: Will it work? Trends Pharmacol. Sci.19, 216–222 (1998). ArticleCASPubMed Google Scholar
Eberhard, A. et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res.60, 1388–1393 (2000). CASPubMed Google Scholar
Heidenreich, R., Kappel, A. & Breier, G. Tumor endothelium-specific transgene expression directed by vascular endothelial growth factor receptor-2 (FLK-1) promoter/enhancer sequences. Cancer Res.60, 6142–6147 (2000). CASPubMed Google Scholar
Hicklin, D.J., Marincola, F.M. & Ferrone, S. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol. Med. Today5, 178–186 (1999). ArticleCASPubMed Google Scholar
Ruiter, D.J., Mattijssen, V., Broecker, E.B. & Ferrone, S. MHC antigens in human melanomas. Semin. Cancer Biol.2, 35–45 (1991). CASPubMed Google Scholar
Cheng, W.F. et al. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J. Clin. Invest.108, 669–678 (2001). ArticleCASPubMedPubMed Central Google Scholar
Wei, Y.Q. et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nature Med.6, 1160–1166 (2000). ArticleCASPubMed Google Scholar
Kisker, O. et al. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res.61, 7669–7674 (2001). CASPubMed Google Scholar
Cross, M.J. & Claesson-Welsh, L. FGF and VEGF function in angiogenesis: signaling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci.22, 201–207 (2001). ArticleCASPubMed Google Scholar
Dias, S. et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J. Clin. Invest.106, 511–521 (2000). ArticleCASPubMedPubMed Central Google Scholar
Drake, C.J., LaRue, A., Ferrara, N. & Little, C.D. VEGF regulates cell behavior during vasculogenesis. Dev. Biol.224, 178–188 (2000). ArticleCASPubMed Google Scholar
Ferrara, N. VEGF: An update on biological and therapeutic aspects. Curr. Opin. Biotechnol.11, 617–624 (2000). ArticleCASPubMed Google Scholar
Folkman, J. & D'Amore, P.A. Blood vessel formation: what is its molecular basis? Cell87, 1153–1155 (1996). ArticleCASPubMed Google Scholar
McMahon, G. VEGF receptor signaling in tumor angiogenesis. Oncologist5 Suppl 1, 3–10 (2000). ArticleCASPubMed Google Scholar
Ortega, N., Hutchings, H. & Plouet, J. Signal relays in the VEGF system. Front Biosci.4, D141–D152 (1999). CASPubMed Google Scholar
Strawn, L.M. et al. FLK-1 as a target for tumor growth inhibition. Cancer Res.56, 3540–3545 (1996). CASPubMed Google Scholar
Taraboletti, G. & Margosio, B. Antiangiogenic and antivascular therapy for cancer. Curr. Opin. Pharmacol.1, 378–384 (2001). ArticleCASPubMed Google Scholar
Ochsenbein, A.F. et al. Roles of tumor localization, second signals and cross priming in cytotoxic T-cell induction. Nature411, 1058–1064 (2001). ArticleCASPubMed Google Scholar
Hata, Y., Rook, S.L. & Aiello, L.P. Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. Diabetes48, 1145–1155 (1999). ArticleCASPubMed Google Scholar
St Croix, B. et al. Genes expressed in human tumor endothelium. Science289, 1197–1202 (2000). ArticleCASPubMed Google Scholar
Niethammer, A.G. et al. An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice. Vaccine20, 421–429 (2001). ArticleCASPubMed Google Scholar
Niethammer, A.G. et al. Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma. Cancer Res.61, 6178–6184 (2001). CASPubMed Google Scholar
Darji, A. et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell91, 765–775 (1997). ArticleCASPubMed Google Scholar
Lode, H.N. et al. Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma. Proc. Natl. Acad. Sci. USA95, 2475–2480 (1998). ArticleCASPubMedPubMed Central Google Scholar
Schrama, D. et al. Targeting of lymphotoxin-α to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity14, 111–121 (2001). ArticleCASPubMed Google Scholar
Kaesler, S., Regenbogen, J., Durka, S., Goppelt, A. & Werner, S. The healing skin wound: A novel site of action of the chemokine c10. Cytokine17, 157–163 (2002). ArticleCASPubMed Google Scholar
Werner, S. et al. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci. USA89, 6896–6900 (1992). ArticleCASPubMedPubMed Central Google Scholar
Barlow, C. et al. Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell86, 159–171 (1996). ArticleCASPubMed Google Scholar
Paylor, R. et al. Alpha7 nicotinic receptor subunits are not necessary for hippocampal- dependent learning or sensorimotor gating: A behavioral characterization of Acra7-deficient mice. Learn. Mem.5, 302–316 (1998). ArticleCASPubMedPubMed Central Google Scholar